MDR EXPRESSION IN NORMAL-TISSUES - PHARMACOLOGICAL IMPLICATIONS FOR THE CLINICAL USE OF P-GLYCOPROTEIN INHIBITORS

Authors
Citation
Bl. Lum et Mp. Gosland, MDR EXPRESSION IN NORMAL-TISSUES - PHARMACOLOGICAL IMPLICATIONS FOR THE CLINICAL USE OF P-GLYCOPROTEIN INHIBITORS, Hematology/oncology clinics of North America, 9(2), 1995, pp. 319-336
Citations number
63
Categorie Soggetti
Oncology,Hematology
ISSN journal
08898588
Volume
9
Issue
2
Year of publication
1995
Pages
319 - 336
Database
ISI
SICI code
0889-8588(1995)9:2<319:MEIN-P>2.0.ZU;2-9
Abstract
In multidrug resistance, the MDR1 gene product, P-glycoprotein (P-gp) is thought to function as an efflux transport pump with broad specific ity for a variety of anticancer drugs. The distribution of Pgp express ion in normal human tissues with secretory function suggests P-gp may have a number of physiologic roles and that impeding P-gp function in these tissues with MDX modulators could result in increased cytotoxin concentrations and enhanced toxicity.